Clinical trial for HIV Prevention
Official title WePrEP: Developing a PrEP Shared Decision-making Tool for Transgender Women
ClinicalTrials.gov ID: NCT06656676
What this study is testing
- What it's testing
- The study wants to see if the tool is easy to use and helpful for transgender women and their providers when deciding between oral or injectable HIV prevention medication.
- Who it's for
- Transgender women who speak English or Spanish and are interested in HIV prevention.
- What's involved
- Participants will use the digital tool with their provider to discuss HIV prevention options and then start the chosen medication. Providers will receive training on the tool and use it during their visits.
- Time commitment
- The study lasts about 6 months, with a few clinic visits and brief follow‑up interviews to evaluate the tool’s use and impact.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65, men only
You may be able to join if
- Self-identify as a transgender woman (e.g., was assigned male at birth, but currently reports a feminine gender identity)
- Be between the ages of 18 and 65
- Currently live in the Denver area
- Speak English or Spanish
- Be HIV-negative (via Alere Determine)
You likely can't join if
- Currently live with HIV
- Do not live in the Denver area
- Do not meet one or more of the inclusion criteria above
See the full eligibility criteria
- Self-identify as a transgender woman (e.g., was assigned male at birth, but currently reports a feminine gender identity)
- Be between the ages of 18 and 65
- Currently live in the Denver area
- Speak English or Spanish
- Be HIV-negative (via Alere Determine)
- Not have participated in the development of WePrEP
- Not have participated in the development of WePrEP
- Live in the Denver area and (as a part of their employment responsibilities) discuss PrEP use with potential end-users.
- Have helped at least 1 TW make a decision about PrEP (e.g., whether or not to use it, which specific PrEP modality, etc...) in the last month.
- Currently live with HIV
- Do not live in the Denver area
- Do not meet one or more of the inclusion criteria above
The study team makes the final eligibility decision.
Where it is enrolling
- Sheridan, Colorado, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Sheridan, Colorado, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.